申请人:MASSACHUSETTS EYE & EAR INFIRMARY
公开号:WO2019148067A1
公开(公告)日:2019-08-01
Compositions for regeneration of inner cells and for treating hearing loss comprise at least one modulator of mechanistic target of rapamycin (mTOR) sufficient to induce reprogramming proliferation and regeneration of inner ear cells. The composition include, in some instances, an effective amount of one or more phosphatase and tensin homolog (PTEN) inhibitors, MYC/NOTCH modulators, Atonal Homolog 1 (Atohl) modulators or combinations thereof.